Can Atlas Arteria Group (ASX:ALX) rebound from a $15.5m interim loss?

Can the company build itself back up after its Macquarie split and shine with in-house management?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

It's been an eventful year for tollroad group Atlas Arteria Group (ASX: ALX), which reported a $15.5 million interim loss as it handed down its half-year results on August 30, after paying out more than $100 million to separate from Macquarie.

Atlas Arteria changed its name from Macquarie Atlas Roads in May when it dropped the parent company as managers and the move has cost the group dearly.

But can the company build itself back up after its Macquarie split and shine with in-house management?

It looks likely.

Atlas Arteria's asset portfolio does look strong, with its 25% stake in the APRR toll-road in France receiving a boost after a rail strike forced commuters to travel on the roads – upping APRR traffic by 4.6% in the six months to June 2018.

Investors will be keen to keep an eye on asset performance for the second half, and it may be difficult to maintain APRR successes now the public transport crisis has quelled, but APRR also showed continued EBITDA margin improvement of 76% in the first half of FY18 from 75.4% for the previous corresponding period.

A total of 50km of road network has been added on the APRR since 2015, with developments currently underway including road widenings, interchanges, link roads and other user improvements.

As such future growth looks inevitable.

Atlas has also made moves to acquire the remaining 30% of Germany's Warnow Tunnel to give it 100% ownership of the asset and earnings on its stake in the A41 in Eastern France rose over the reporting period.

The half-year results revealed a 3.4% increase in Atlas's aggregate portfolio traffic and a 5.6% lift in proportionate revenue to $559.9 million.

EBITDA rose 6.2% to $429.1 million.

And while the separation from Macquarie ate into profits this time, the company should benefit from its Macquarie split going forward, with running costs estimated to be between $15 million and $20 million a year with internalised management – much less than they were forking out for Macquarie.

UBS slapped a buy rating on Atlas back in April when internalisation plans were announced and Credit Suisse has forecast good growth for the stock over the medium term, but many investors interested in the sector have their eyes on Transurban Group (ASX: TCL) right now.

Transurban is currently in a trading halt ahead of its $4.8 billion capital raising to fund the acquisition of a 51% stake in Sydney's WestConnex tollway.

Transurban's capital raising is certainly substantial and the company would be granted a 42.5 year concession over WestConnex if all goes well – a road projected to save 40 minutes of travel time between Sydney Airport and Paramatta by 2031 with 40% of Sydney's population said to live within 5km of the network.

Transurban's annual report is due to be handed down on September 7.

Another large cap cousin to keep an eye on at the moment is Sydney Airport (ASX: SYD) after its recent report showed passenger numbers were climbing as more flights and locations are added to its offering.

Sydney Airport posted a 7.9% rise in half-year revenue to $770.8 million with interim earnings before tax, depreciation and amortisation coming in at $623.4 million – up 8%.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Sydney Airport Holdings Limited and Transurban Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Two happy and excited friends in euphoria holding a smartphone, after winning in a bet.
Broker Notes

3 ASX shares upgraded by Morgans to buy ratings

Let's see why the broker has turned positive on these shares.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing start to the trading week.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Wooden blocks spelling rebound with coins on top.
Broker Notes

Can Life360 shares recover from the AI fuelled sell-off?

A leading expert looks into the AI-driven pressure hitting Life360 shares.

Read more »

An engineer takes a break on a staircase and looks out over a huge open pit coal mine as the sun rises in the background.
Broker Notes

Up 49% in a year, should you buy BHP shares for their 'stability and income'?

A leading expert delivers his forecast for BHP’s fast-rising shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Pro Medicus, Life360, A2 Milk shares

Expert analysts reveal their latest recommendations on 3 ASX 200 stocks.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Atlas Arteria, Forrestania, Megaport, and WA1 shares are charging higher today

These shares are starting the week positively. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today

These shares are starting the week in the red. Let's find out why.

Read more »